61 results
424B5
CKPT
Checkpoint Therapeutics Inc
30 Jan 24
Prospectus supplement for primary offering
5:10pm
, and prospective investors. The engagement agreement does not give rise to any commitment by the placement agent to purchase any of the securities … , and the placement agent will have no authority to bind us by virtue of the engagement agreement. The placement agent is not purchasing the securities offered
8-K
o1442bwj
30 Jan 24
Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market
5:00pm
8-K
EX-4.3
k9z45 iovhvjfhmx8
30 Jan 24
Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market
5:00pm
8-K
mxu wvi7b
3 Oct 23
Checkpoint Therapeutics Announces Exercise of Warrants for $11.13 Million in Gross Proceeds
5:00pm
8-K
EX-4.2
aj2qch41
3 Oct 23
Checkpoint Therapeutics Announces Exercise of Warrants for $11.13 Million in Gross Proceeds
5:00pm
8-K
xi1prwyn
31 Jul 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market
8:28am
8-K
EX-4.3
0endf3l djcvhk3
31 Jul 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market
8:28am
424B5
60zc4 q5t
31 Jul 23
Prospectus supplement for primary offering
8:23am
424B5
6wasljrujne7k4u9u
24 May 23
Prospectus supplement for primary offering
5:25pm
8-K
4wwbyb
24 May 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5:24pm
8-K
EX-4.3
ld3r yu8nxu6
24 May 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5:24pm